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An increasing body of evidence suggests that mechanisms related to the introduction and repair of DNA double strand breaks
(DSBs) may be associated with long-termmemory (LTM) processes. Previous studies from our group suggested that factors known
to function in DNA recombination/repair machineries, such as DNA ligases, polymerases, and DNA endonucleases, play a role in
LTM. Here we report data using C57BL/6 mice showing that the V(D)J recombination-activating gene 1 (RAG1), which encodes a
factor that introduces DSBs in immunoglobulin and T-cell receptor genes, is induced in the amygdala, but not in the hippocampus,
after context fear conditioning. Amygdalar induction of RAG1 mRNA, measured by real-time PCR, was not observed in context-
only or shock-only controls, suggesting that the context fear conditioning response is related to associative learning processes.
Furthermore, double immunofluorescence studies demonstrated the neuronal localization of RAG1 protein in amygdalar sections
prepared after perfusion and fixation. In functional studies, intra-amygdalar injections of RAG1 gapmer antisense oligonucleotides,
given 1 h prior to conditioning, resulted in amygdalar knockdown of RAG1 mRNA and a significant impairment in LTM, tested
24 h after training. Overall, these findings suggest that the V(D)J recombination-activating gene 1, RAG1, may play a role in LTM
consolidation.
1. Introduction
Studies suggest that LTM consolidation depends on the
morphological establishment, maintenance, and rearrange-
ment of specific neural networks, which includes the
strengthening of synapses or the formation of new connec-
tions within specific brain areas involved in learning and
memory [1–4]. Importantly, concurrently with morpholog-
ical changes of synaptic connections, transient induction of
new gene transcription and protein synthesis are required
for LTM formation [5–7]. Indeed, it has been shown that
pharmacological blockade of transcription or translation, as
well as the targeted mutation of transcription and translation
factors, inhibits LTM consolidation [8–11].
One limitation with the current model used to explain
LTM consolidation is that at the cellular level synaptic
connections and electric patterns are highly dynamic and
unstable, while memories can endure for months, years, and
even decades. Similarly, at the molecular level, mRNA and
proteins undergo molecular turnover. Some have suggested
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that epigenetic modulation may explain the permanence
of memories [12–15]; however, histone modifications are
highly dynamic and reversible [16, 17]. In addition, the rapid
turnover rate of transcriptionally active chromatin is a com-
mon feature in all nonproliferating cells, including neurons
[18–20]. Similarly, DNA methylation and demethylation are
dynamic and reversible even in nondividing cells, such as
neurons [17, 21]. Hippocampal DNA methylation changes
following learning are rapid, but these changes are plastic,
not permanent [14, 22]. Moreover, epigenetic mechanisms
that chemically modify histones or genomic DNA both
regulate transcription. Hence, epigenetic mechanisms most
probably function by temporarily regulating transcription
during memory and plasticity processes.
In order to assess these questions, our group, as well as
others, has been carrying out alternative studies in order
to evaluate the possible role of other potential mechanisms
that might also be relevant to LTM consolidation. Specif-
ically, we initially postulated that mechanisms involved in
DNA recombination/repairmay contribute to LTMprocesses
[23]. In the immune system, DNA recombination of gene
segments is a well-controlled process involving the activation
of DNA endonucleases, which in turn generate DNA DSBs,
as well as activation of DNA ligases and DNA repair factors
for rejoining new gene segments [24–26]. Interestingly, a
recent study reported that when mice explored a novel
environment, DNA DSBs were accumulated throughout the
brain, particularly in the hippocampus, a region involved
in learning and memory [27]. Moreover, these DNA DSBs
were repaired within 24 h, suggesting that a physiological
machinery for the introduction and repair of these DNA
lesions may be related to learning and memory processes.
Furthermore, subsequent studies reported that DNA DSBs
are introduced in the promoters of a subset of immediate early
genes including Fos, Npas4, and Egr1 in response to neuronal
activity, synaptic plasticity processes, and learning [28]. Con-
sistent with these findings, we previously reported that Fen-
1 endonuclease [29], terminal deoxynucleotidyl transferase
(TdT), a template-independent DNA polymerase involved in
V(D)J recombination [30], DNA ligase [31, 32], and Non-
Homologous End Joining (NHEJ) activity [32, 33] are DNA
recombination/repair factors or machineries regulated by
and/or required for learning and memory processes.
Here, we report that the V(D)J recombination-activating
gene 1 (RAG1), which is key to initiating V(D)J recombination
in lymphocytes [34–37], is a factor modulated by context
fear conditioning in young adult mice and that its amygdalar
expression is required for LTM. Quantitative real-time PCR
indicated that RAG1 mRNA is induced in the amygdala, but
not in the hippocampus, after conditioning. Such induction
is related to associative learning, rather than to the nonasso-
ciative behavioral experiences related to context fear condi-
tioning, as determined with Naı¨ve, context-only, and shock-
only controls. Additional control experiments confirmed the
sequence identity between amygdalar and thymusRAG1 PCR
products, both showing 100% match to Mus musculus RAG1
in BLAST analyses. Moreover, double immunofluorescence
studies indicated that RAG1 protein is expressed within
amygdalar neurons. The functional relevance of RAG1 was
examined using gapmer antisense, versus random oligonu-
cleotides infused directly into the amygdala either immedi-
ately prior to or 5 h after conditioning. Pretraining infusions
resulted in amygdalar knockdown of RAG1 mRNA and a
significant impairment in LTM, while posttraining infusions
did not affect LTM. Together, these findings suggest that
RAG1 plays a role in LTM consolidation.
2. Materials and Methods
The Institutional Animal Care and Use Committee (IACUC)
of the Rı´o Piedras Campus of the University of Puerto Rico in
compliance with National Institutes of Health (NIH) guide-
lines for the care and use of laboratory animals (Department
of Health and Human Services NIH publication number 86-
23) approved all procedures involving animals.
2.1. Contextual Fear Conditioning
2.1.1. Apparatus. Our conditioning chamber (30 × 20 ×
18 cm) was made of transparent Plexiglas on two sides and
stainless steel on the other two sides. Each of the steel sides
had a speaker and a 24V light. The chamber had a 36-bar-
insulated shock grid floor made of stainless-steel rods (Coul-
bourn Instruments, Allentown, PA). The system included a
white-noise generator to provide background noise (70 dB).
The floor was removable and was cleaned with 70% ethanol
after each subject was trained, reexposed, or tested. Each bar
(1.5 cm in diameter) was connected through a harness to a
programmable Master Shocker (model 82404SS; Coulbourn
Instruments) that delivered scrambled foot shocks to each
of the bars in the grid floor. A mini camera (Silent Witness
Enterprises, Surrey, British Columbia, Canada) installed
directly behind one of the two Plexiglas sides of the condi-
tioning chamber was connected via a processor to a computer
system for video recording and scoring of freezing using the
Xpress SDK software, which is a PCI bus mastering wavelet
video compression/decompression and capture board (Inte-
gral Technologies, Indianapolis, IN).
2.1.2. Subjects and Training. Context conditioning was done
essentially as previously described [11, 32, 38]. Male C57BL/6
mice of 8–10 weeks of age from Harlan Sprague Dawley,
Indianapolis, IN, were used. Food and water were available
at all times, and the animals were kept on a 12 h light/dark
cycle. In contextual fear conditioning, animals were placed
in the conditioning chamber (conditioned stimulus, CS) and
allowed to explore for 2min (habituation). Animals then
received three foot shocks of 0.75mA for 2 s (unconditioned
stimulus, US) delivered at 2, 3, and 4min. Mice remained
in the chamber 30 s after the last shock and were then
immediately moved to their home cages.
2.2. RNA Extraction, Quantification, and Quality Evaluation.
Once trained, animals were decapitated at 15min, 30min,
or 1 h after conditioning. Some animals were also used
as Na¨ıve, 15min context-only (CO) and 15min shock-only
(SO) controls. CO mice were exposed to the conditioning
context for 4m without receiving any shocks and SO mice
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received a rapid single shock and were immediately removed
from the conditioning chamber. After removal from the
conditioning chamber, both CO and SO mice were returned
to their homecages and sacrificed 15min after the end of their
exposure to the conditioning chamber. Brains were rapidly
obtained, chilled in ice-cold Phosphate Buffered Saline (PBS),
and then transferred to a mouse brain matrix to obtain
bilateral amygdalar tissue punches and dissection of the dor-
sal hippocampus, both between −0.82 and −2.70mm from
bregma points, based on the mouse brain in stereotaxic coor-
dinates, third edition [39]. All tissues were kept in RNAlater
(Ambion, Cat. number 7020) solution on dry ice and later
stored at −86∘C until RNA extraction. RNA was extracted
from individual dorsal hippocampi using the Qiagen RNeasy
Mini Kit (Cat. number 74104), while bilateral amygdalar
punches were RNA extracted using theQiagen RNeasyMicro
Kit (Cat. number 74004). Extracts were treated using DNase
(Qiagen, 79254) and the kit’s protocol was performed. RNA
samples were quantified using the NanoDrop ND-1000 spec-
trophotometer and quality was evaluated using the Agilent
2100 Bioanalyzer system.
2.3. Quantitative Real-Time PCR
2.3.1. Primer Design for Real-Time PCR. cDNA sequences
fromMusmusculus genes analyzed [RAG1, accession number
NM 009019.2; and glyceraldehyde 3-phosphate dehydrogenase
(gapdh), accession number NM 008084.2] were obtained
from GenBank. We used the Integrated DNA Technologies
PrimerQuest and Oligo Analyzer bioinformatics tools to
design specific primers suitable for real-time PCR and also
avoid possible hairpins, self/homodimers, and hetero/cross-
dimers. A BLAST (basic local alignment search tool) search
was done on all primers to ensure that they would not poten-
tially anneal to other targets. The following forward and
reverse primers were used: RAG1, forward, 5󸀠-TGA GCA
CAG GCA AGC TGA TGA-3󸀠 and RAG1 reverse, 5󸀠-TTG
ACA CGG ATG GCC AAG CAA-3󸀠; for gapdh forward 5󸀠-
ACC CAG AAG ACT GTG GAT GG󸀠-3 and gapdh reverse
5󸀠-ACA CAT TGG GGC TAG GAA CA-3󸀠. All primers were
synthesized by Integrated DNA Technologies.
2.3.2. cDNA Synthesis and Quantitative Real-Time PCR.
Briefly, cDNA was synthesized using the TaqMan Reverse
Transcription (RT) Reagents kit (N8080234, Applied Biosys-
tems/Roche). 250 ng of RNA, 2.5 𝜇L of RTBuffer (10x),
6.0 𝜇L MgCl
2
(25mM), 5.0 𝜇L dNTPs (10mM, 2.5mM, each
nucleotide), 2.0𝜇L OligodT (50 𝜇M), 0.5 𝜇L RNase inhibitor
(20U/𝜇L), and 3.0 𝜇LRTEnzyme (50U/𝜇L) in a total volume
of 25 𝜇Lwere used.Thermal cycler conditionswere as follows:
25∘C for 10min, 48∘C for 30min, 95∘C for 5min, and 4∘C
forever. Real-time PCR was performed using the QuantiTect
SYBR Green PCR Master Mix Kit (Qiagen, 204163). Real-
time PCR amplification conditions were optimized for each
gene and we obtained the best results under the following
master mix conditions: for housekeeping control gene gapdh
we used 12.5 𝜇L of SYBR Green Master Mix, 2.5 𝜇L of each
primer (5 𝜇M), and 2 𝜇L of cDNA in 25𝜇L of reaction. For
RAG1, we used 12.5 𝜇L of SYBR Green Master Mix, 3.5 𝜇L
of each primer (5 𝜇M), 1.5 𝜇L of MgCl
2
(25mM), and 2 𝜇L
of cDNA in 25 𝜇L of reaction. Real-time PCR amplifications
were run in triplicate for each gene per sample in a ther-
mal cycler (Bio-Rad C1000 Touch CFX96 Real-Time PCR
System). Amplification conditions were optimized for both
genes at 95∘C 15min (hot start), followed by 40 cycles at 95∘C
for 15 s, 30 s at 58∘C, and 72∘C for 30 s. Finally, a melt/peak
curve analysis was performed from 55∘C to 95∘C at increasing
temperature rate of 0.5 degrees.
2.3.3. Real-Time PCR Analysis. We used the comparative
threshold cycle (Delta Ct) method of relative quantification
to calculate gene expression levels [40]. Delta Ct method
involves comparing the Ct values of the genes of interest
with a reference or housekeeping gene: Ct = Ct Target −
Ct Reference gene (Ctt − Ctr). In this case, the Ct value
of RAG1 primers’ amplification product is subtracted from
the Ct of gapdh primers’ amplification product (Ct
𝑅𝐴𝐺1
−
Ct
𝑔𝑎𝑝𝑑ℎ
). First, the Ct-average of triplicates per gene per
sample from PCR amplification was obtained. Importantly,
our analyses only used samples displaying triplicate results
with high reproducibility, that is, those showing triplicate
differences in Ct of no more than 0.05%. In the case that the
real-time PCR experiments of a particular sample resulted in
low reproducibility, such specific experiments were repeated
or in some cases discarded, always making sure that the final
analyses could be made with the result of triplicate reactions
per sample. As Ct is proportional to the logarithm of initial
amount of target in a sample, the relative concentration of one
target contextual fear conditioning-trained with respect to a
reference (Naive) is reflected in the difference in cycle number
(Ct) necessary to achieve the same level of fluorescence. Delta
Ct data is then normalized by 2−(deltaCt trained−deltaCt naive).
2.4. Amplification and Molecular Cloning of RAG1 PCR Prod-
ucts. We amplified a RAG1 mRNA fragment of approxi-
mately 48 bp (the same from the real-time PCR experiments
described above) from amygdalar, hippocampus, and thy-
mus tissue and also cloned the resulting PCR products for
sequence analysis. Briefly, following RNA extraction and
purification (as above), cDNA was synthesized using Taq-
Man Reverse Transcription Reagents kit (N8080234, Applied
Biosystems/Roche). 500 ng of RNA from each sample was
used and mixed with 2.5 𝜇L of RT Buffer (10x), 4.5 𝜇L MgCl
2
(25mM), 4.0 𝜇L dNTPs (10mM, 2.5mM each nucleotide),
2.0 𝜇L OligodT (50 𝜇M), 0.5 𝜇L RNase inhibitor (20U/𝜇L),
and 3.0 𝜇L of RT Enzyme (50U/𝜇L) in a total volume of
25 𝜇L. cDNA synthesis was performed in a thermal cycler
(GeneAmpPCR System 9700, Applied Biosystems) under the
following conditions: 25∘C for 10min, 48∘C for 30min, 95∘C
for 5min, and 4∘C forever. PCRwas performed using the PCR
Master Mix (2x) (2 × 50 reactions) Kit (Promega, M7502).
PCR amplification conditions were performed under the fol-
lowingmastermix conditions: 12.5𝜇L ofmastermix, 3.5𝜇L of
each primer (5 𝜇M, the same primers used for real-time PCR
experiments), 1.5 𝜇L ofMgCl
2
(25mM), and 2 𝜇L of cDNA in
25 𝜇L of reaction. Amplificationswere performed by an initial
denaturation at 95∘C for 30 s, followed by 40 cycles at 95∘C
for 15 s, 58∘C for 30 s, and 72∘C for 30 s, and final extension
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at 72∘C for 7min followed by 4∘C forever. PCR amplifications
were evaluated by agarose (1%) gel electrophoresis in TAE1X
and stained with ethidium bromide. PCR products were
purified from the gel using the QIAquick Gel Extraction
Kit (50), following the kit protocol manual (Qiagen, 28704).
Purified PCR products were cloned using the pGEM-T Easy
Vector System I (Promega, A1360).DNA ligation and plasmid
transfection were performed as recommended by the kit’s
protocol. For plasmid transfection we used E. coli (from
Invitrogen, 18258-012) MAX Efficiency DH5𝛼 Competent
Cells. Cells were plated onto LB/ampicillin agar medium
containing IPTG and X-Gal.
2.5. Plasmid DNA Extraction and Purification for Sequencing.
Minipreps for sequencing were performed using a modi-
fication of standard methods [41]. Briefly, a single white
bacterial colony was transferred into 3mL of Terrific Broth
mediumcontaining ampicillin in a loosely capped 15mL tube.
Cells were cultured overnight at 37∘C with vigorous shak-
ing. Harvest and extraction was performed as indicated in
standard methods [41], but we also did additional successive
purification steps, including RNase A treatment, exonuclease
digestion, and proteinase K incubation. After two chloroform
extractions and isopropanol precipitations, pelletswere dried,
dissolved in 50 𝜇L of H
2
O, and mixed with 12 𝜇L of NaCl
4M and 60 𝜇L of freshly made polyethyleneglycol 13% (PEG
8000). The mixture was incubated on ice for 30–60min and
centrifuged for 15min and the pellet was rinsed with ethanol
70%. Finally, pellets were dried and dissolved in 50𝜇L ofH
2
O.
Samples were kept in −20∘C until used. Sequencing reactions
were performed using the BigDye Terminator Chemistry v.3
in an ABI 3130xl Genetic Analyzer. DNA sequences were
analyzed by BLAST against themouse genome (RefSeq RNA)
and aligned using ClustalW2.
2.6. Histology: Brain Perfusion and Tissue Preparation. One
hour after context fear conditioning, animals received a lethal
dose of avertin and were immediately followed by transcar-
dial gentle perfusion with PBS buffer for 5min. After that, we
switched to the fixing buffer (4% paraformaldehyde, pH 7.4)
for 5min. Brains were extracted, fixed in 4% paraformalde-
hyde solution for 24 h, and later cryoprotected overnight in a
30% sucrose solution and finally frozen at −86∘C for storage
until future use. Frozen brains were used to collect 20 𝜇m
thick coronal sections selecting specifically those containing
the amygdala region between −1.06 and −2.30mm bregma
points, based on the mouse brain in stereotaxic coordinates,
third edition [39]. The collected sections were placed onto
positively charged slides (Probe-On Plus Slides, Fisher, PR)
and kept at −86∘C until used for immunofluorescence.
2.7. Immunofluorescence. To examine the cellular localization
of RAG1 protein expression, slides were dried up at rt for
30min. Using a heat block set at 200∘C, a beaker flask con-
taining the buffer (800mL ddH
2
O, 4mL 1M Tris pH 8, and
1.6mL 0.5M EDTA) was heated until boiling. Once the
buffer’s bubbles were moving slowly, slides were slowly
immersed into the buffer using a slide-rack. The beaker was
immediately covered with a saran wrap containing holes
punched with a pipet tip and was allowed to sit for 20min.
The beaker containing the slides was then transferred into an
ice bath and allowed to cool down in a cold room (4∘C) for
30min. Slides were partially dried and borders drawn with
PAP-Pen. Then, 250𝜇L of blocking solution (BS) (1x PBS,
10% normal goat serum, and 0.1% Tween-20) was added per
slide and incubated for 1 h at rt. Double immunofluorescence
was performed, incubating the sections with primary rabbit
polyclonal antibody against human RAG1 (Sigma-Aldrich:
SAB2106610) diluted at 1 : 100 in 1% goat serum/PBS together
with primary anti-NeuN mouse monoclonal antibody (Mil-
lipore, MAB377) diluted at 1 : 100. Incubation with primary
antibodies was done overnight at 4∘C in a moist chamber.
Slides were washed with PBS 3 times for 5min each. Slides
were then incubated for 2 h at rt in the dark moist chamber
with Alexa Fluor 488-conjugated goat anti-rabbit IgG sec-
ondary antibody (Invitrogen) (for detection of RAG1) and
Alexa Fluor 568-conjugated goat anti-mouse IgG secondary
antibody (Invitrogen) (for detection of NeuN), both diluted
at 1 : 200 in 1% goat serum/PBS, followed by 3 PBS washes for
5min each. Slides were mounted using permanent mounting
medium (Vector Laboratories). All slides were first scanned
at low magnification (10x) to locate the amygdala, which was
subsequently analyzed at higher magnification (40x) using
a Zeiss LSM-5 Pascal scanning confocal microscope. Final
image composites were created using Zeiss LSM5 PASCAL
Image software, version 3.2.
2.8. Protein Extraction. Mice were decapitated 1 h after
training and their brains were obtained, chilled on ice-
cold PBS, and used to dissect the amygdala as previously
explained, between −0.82 and −2.7mm bregma points, based
on the mouse brain in stereotaxic coordinates [39]. Bilateral
amygdalar tissue punches from three animals were combined
yielding one pool sample per group. Thymus, bone marrow,
and muscle tissues were also dissected as controls. Tissues
were stored at−86∘Cuntil used for protein extraction. Protein
extracts were prepared as described by us previously [29, 31–
33]. Briefly, tissues were homogenized using a sonic dismem-
brator in extraction buffer [30mM HEPES/KOH, pH 7.9,
0.5M KCl, 5mM MgCl
2
, 1 mM EDTA, 2mM dithiothreitol
(DTT), 20% glycerol, 1mM phenylmethylsulfonyl fluoride
(PMSF), and 1 𝜇g/mL of each of leupeptin and aprotinin]
and incubated for 1 h on ice. Extracts were centrifuged at
14,000 rpm for 1 h at 4∘C. The supernatant was then dialyzed
for 4 h in dialysis buffer (30mMHEPES/KOH, pH7.9, 50mM
KCl, 2mM EDTA, 5mM MgCl
2
, 1 mM DTT, 10% glycerol,
1mMPMSF, and 1 𝜇g/mL of each of leupeptin and aprotinin).
Dialyzed fractions were centrifuged at 14,000 rpm for 30min
at 4∘C. Protein extracts were stored at −86∘C until used for
Western blots. The protein concentration was determined in
the NanoDrop ND-1000 spectrophotometer.
2.9. Western Blotting. For Western blotting, protein samples
(50 𝜇g) and 4 𝜇L of the Odyssey PrestainedMolecularWeight
Marker (LI-COR Biosciences, Nebraska, USA) were first
separated on a 8% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE). The separated proteins in
the gels were transferred to a nitrocellulose membrane using
Neural Plasticity 5
a semidry electroblotter system at 15V for 1 h and 30min.
Then, themembraneswere blocked overnight using amixture
of 5% nonfat milk and Odyssey Blocking Buffer (LI-COR
Biosciences, Nebraska, USA) on an orbital shaker. After 3
washes of 15min each with PBS Tween-20 (PBS-T), the
membrane was incubated with a mixture of two primary
antibodies: 1 : 2,000 dilution of a rabbit polyclonal antibody
raised against a synthetic nonphosphopeptide derived from
human RAG1 (Sigma-Aldrich: SAB2106610) and 1 : 3,000
dilution of a mouse monoclonal anti-actin antibody (Sigma-
Aldrich: A4700) at 4∘C overnight. After 3 washes of 15min
each with PBS-T, the membranes were incubated with a
mixture of two secondary fluorescent antibodies (1 : 10,000
dilution of donkey anti-rabbit IRDye680 and 1 : 12,000 dilu-
tion of donkey anti-mouse IRDye800) (LI-COR Biosciences,
Nebraska, USA) for 2 h at rt. The membranes were washed 3
times as previouslymentioned and scanned for analysis using
the Odyssey Infrared Imaging System.
2.10. Antisense Knockdown Experiments
2.10.1. RAG1 Antisense Oligonucleotides for Gene Knockdown.
Gapmer antisense oligonucleotides were designed to target
the start codon of mouse RAG1 mRNA. This 20 bp gapmer
contains a central block consisting of ten phosphorothioate-
deoxynucleotides, sufficient to induce RNaseH cleavage (and
thus targeted RNA:DNA hybrid degradation), and it is
flanked by two blocks, each consisting of five 2󸀠-O-methyl-
modified ribonucleotides that protect the internal phospho-
rothioate-deoxynucleotide block from nuclease degradation,
thus increasing stability. As a control, a random sequence
was also designed with the same backbonemodifications and
base composition as the RAG1 antisense, but in a scram-
bled sequence order and without homology to any known
mouse gene. RAG1 antisense and random oligonucleo-
tide sequences were, respectively, as follows: 5󸀠-mGmCmC
mAmCA∗ G∗A∗G∗ A∗T∗A∗ G∗C∗A∗ mAmCmA mUmA-
3󸀠 and 5󸀠-mCmAmG mAmUA∗ A∗C∗C∗ G∗T∗A∗ G∗A∗G∗
mCmAmA mCmA-3󸀠 (where “m” represents 2󸀠-O-methyl
RNA and “∗” represents phosphorothioate DNA). Anti-
sense and random sequences were synthesized by Integrated
DNA Technologies. All batches of antisense and random
oligonucleotides used to complete these studies were received
lyophilized and fully purified by RNase Free HPLC. Oligo-
nucleotides were dissolved in sterile 1x TE buffer pH 7.5
solution to a final concentration of 0.2 nmol/𝜇L.
2.10.2. Surgeries. Several surgeries were conducted to deter-
mine the proper coordinates for implantation of cannulae
into the amygdala, based on the mouse brain in stereotaxic
coordinates [39]. For surgery, animals were anesthetized
with avertin and placed into a stereotaxic apparatus (David
Kopf Instruments), with the nose angled at 0∘. After a scalp
incision was made, lambda and bregma were located, and
holes were drilled in the skull above the target region.
Bilateral cannulae (23 gauges) guide (6.8mm wide) was
implanted above the amygdala in order to avoid damaging the
amygdala tissue complex with cannulae and injectors while
at the same time ensuring amygdala-enriched distribution.
The following coordinates were used: anterior-posterior,
+1.0mm from bregma; medial-lateral, −3.4mm from mid-
line; and dorsoventral, −2.5mm from skull. The cannulae
were secured to stainless-steel screws with dental cement and
a light-curable resin. Wire stylets (33 gauges) were inserted
into the cannulae guides and checked every day to ensure
clean and functional cannulae.
2.10.3. Intra-Amygdalar OligonucleotideMicroinfusions, Behav-
ioral Training, and Memory Testing. After surgery, animals
were given a two-day period to recover. Afterwards, animals
were handled during 3 days, 3min each. The fourth day,
animals were bilaterally microinfused with 1𝜇L of 1x TE
buffer pH 7.5 (2min at 0.5 𝜇L/min), as a handling/stress con-
trol, and then we proceeded with the regular 3min manual
handling. Microinfusions were accomplished by inserting a
33-gauge stainless-steel injector into the guide cannulae so
that it extended 1mm beyond the tip of the guide, right above
the targeted amygdalar complex (see above). Functionality
of injectors was verified before every microinfusion between
animals and replaced when necessary. After infusion, the
injectors were removed, and the stylets were replaced. The
fifth day, animals were bilaterally microinfused (2min at
0.5 𝜇L/min) with 0.2 nmol of RAG1 antisense or random
sequence oligonucleotides, handled for 3min, and returned
to their home cages. One hour after the microinfusions,
animals were trained in context fear conditioning and video
recorded as described above. One day (24 h) after training
mice were reintroduced into the same conditioning con-
text for LTM testing by measuring freezing in the video
recordings for 4m, but they did not receive shocks. For
the posttraining injection studies, a different set of animals
was treated as above except that the antisense or random
oligonucleotide treatment was given 5 h after context fear
conditioning instead of 1 h prior to training. For the reconsol-
idation studies, another set of mice was subjected to surgery
cannulation and received handling as above, but in the fifth
day, mice were microinfused with saline (as a stress control)
and trained in context fear conditioning 1 h later. Next, 24 h
after conditioning, animals were microinfused with either
random or antisense oligonucleotides 1 h prior to reexposure
to the conditioning chamber and video recorded for 90 s for
memory retrieval without receiving any shocks. Finally, 48 h
after conditioning (24 h after context reexposure), mice were
again reexposed to the conditioning chamber for 2min to
measure freezing of LTM in the reconsolidation test.
2.10.4. Diffusion Studies. After cannulae implantation, injec-
tors were inserted and animals (𝑛 = 4) were infused with
FITC-RAG1 antisense oligonucleotides to estimate the area of
the antisense diffusion within the amygdala. An infusion of
1 𝜇L of FITC-RAG1 antisense oligonucleotide (0.2 nmol) was
delivered bilaterally into the amygdala during a 2min period
at a rate of 0.5 𝜇L/min. Animals were decapitated 3 h after
infusion, and their brains were isolated and stored at −86∘C.
Coronal amygdalar sections, 20𝜇m thick, were scanned at
low magnification (10x) to locate the amygdala, which was
subsequently analyzed at higher magnification (20x and 40x)
using a Zeiss LSM-5 Pascal scanning confocal microscope.
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Images were processed using Zeiss LSM5 PASCAL Image
software, version 3.2.
2.11. Statistical Analysis. All statistical analyses were per-
formed with Prism 4 software (GraphPad Software). Statis-
tical significance was assumed at 𝑃 < 0.05. Real-time PCR
experiments of RAG1 mRNA levels were analyzed by One-
Way ANOVA andNewman-Keuls posttests to compare RAG1
mRNA expression between behavioral groups. Real-time
PCR experiments of perfused and nonperfused mice for
RAG1 levels were analyzed using Student’s 𝑡-test. Knock-
down validation of RAG1 antisense mRNA levels in the
amygdala compared to random was analyzed by Student’s 𝑡-
test. Memory acquisition behavioral data was subjected to
Two-Way Repeated Measures (RM) ANOVA and Bonferroni
posttesting. LTM behavioral tests analyses were analyzed by
Student’s 𝑡-test. Memory retrieval and reconsolidation tests
were analyzed by Two-Way ANOVA coupled to Bonferroni
posttesting.
3. Results
3.1. Context Fear Conditioning Learning Specifically Induces
RAG1 mRNA Expression in the Amygdala. DNA recombina-
tion/repair processes involve the activation of endonucleases
as well as DNA ligases and polymerases, among other factors.
We focused our present studies on RAG1, the gene encoding
the specialized recombinase of V(D)J recombination, which
initiates V(D)J recombination in lieu of its site-specific endo-
nuclease activity that targets highly specific recombination
signal sequences (RSSs) introducing DNA DSBs in antigen
receptor genes [34, 36, 37, 42] and which we identified in
a preliminary DNA microarray screen as a potential can-
didate gene involved in context fear conditioning. For the
experiments reported here, we initially trained C57BL/6male
mice in context fear conditioning, sacrificed at 15, 30, or
60min after training, and obtained dorsal hippocampi and
amygdalar tissues. We used quantitative real-time PCR to
amplify a fragment of RAG1 mRNA and determine whether
the expression of this gene is modulated in the amygdala or
the hippocampus in association with context fear condition-
ing learning. The results of these experiments are shown in
Figure 1. As seen in Figure 1(a), when examining hippocam-
pal RAG1 mRNA no significant differences were observed
between the Na¨ıve (Naive, 𝑛 = 6) and the conditioned (C)
groups sacrificed at either 15 (𝑛 = 7), 30 (𝑛 = 7), or 60 (𝑛 = 7)
min after training (One-Way ANOVA: 𝐹(3, 23) = 0.8966,
𝑃 > 0.05). The results demonstrate that the basal levels of
hippocampal RAG1 mRNA do not change significantly after
training. In contrast to our findings with the hippocampus,
we found that context fear conditioning training results in a
significant, rapid, and transient induction inRAG1 amygdalar
mRNA levels (Figure 1(b): One-Way ANOVA, 𝐹(3, 30) =
4.753, ∗∗𝑃 < 0.01; Multiple Comparison Testing: Na¨ıve
versus C15min, ∗𝑃 < 0.05; Na¨ıve versus C30min, #𝑃 < 0.05;
Na¨ıve versus C60min, 𝑃 > 0.05; C60min versus C30min,
+
𝑃 < 0.05; and C60min versus C15min, 𝑃 > 0.05). Overall,
these results show that RAG1 mRNA is induced rapidly and
transiently after context fear conditioning training in the
amygdala, but not the hippocampus, of young adult C57BL/6
mice. For our next set of experiments, we aimed to determine
if such amygdalar induction is specific to associative context
fear conditioning, using nonassociative context-only (CO,
𝑛 = 6) and shock-only (SO, 𝑛 = 8) controls, in which the con-
ditioned stimulus (CS) (for CO controls) or unconditioned
stimulus (US) (for SO controls) was presented individually,
rather than paired. We sacrificed animals from the C (𝑛 = 9),
CO, or SO groups 15min after their respective associative
or nonassociative training. Brains were obtained, amygdalar
tissue punches were dissected, and RNAwas extracted. Na¨ıve
animal controls were also used (Naive, 𝑛 = 8).The results can
be seen in the bar graph in Figure 1(c). The results again
confirmed the induction at 15min of amygdalarRAG1mRNA
after context fear conditioning compared to Na¨ıve, CO, or
SO controls and showed no statistical significant difference
between any of these controls (One-Way ANOVA, 𝐹(3, 27) =
5.943, ∗∗𝑃 < 0.005; Multiple Comparison Testing: Naive ver-
susC15min, ∗∗𝑃 < 0.01; SO15min versusC15min, #𝑃 < 0.05;
CO15min versus C15min, ++𝑃 < 0.01; SO15min versus Naive,
𝑃 > 0.05; SO15min versus CO15min, 𝑃 > 0.05; CO15min
versus Naive, 𝑃 > 0.05). Finally, since the results presented
so far were obtained from tissue samples obtained from
nonperfused brains, we carried out an additional control
experiment to determine if the observed changes in RAG1
mRNA levels could be attributed to the presence of blood
cells in the brain or not, since immune cells in the blood
are a known biological site of RAG1 expression [43, 44]. We
trained two groups of mice in context fear conditioning and
sacrificed animals of both groups 30min after training, a
time corresponding to the peak for amygdalar RAG1 mRNA
induction observed after training (see Figure 1(b)).The brains
of animals in one group were obtained as described above.
For the second group of animals, mice were injected with a
lethal dose of avertin 25min after training and perfused for
3min with PBS-1X in order to remove the blood from their
brains. Brains from both groups of animals were extracted
and amygdalar tissues (𝑛 = 4 nonperfused; 𝑛 = 4 perfused)
were dissected. Amygdalar tissues were used for further RNA
isolation, cDNA synthesis, and quantitative real-time PCR
analysis of RAG1 mRNA. The results showed no significant
difference between the levels of amygdalar RAG1 mRNA
30min after context fear conditioning training of nonper-
fused (1.304 ± 0.3377) or perfused (1.274 ± 0.2751) mice (Stu-
dent’s 𝑡-test; 𝑡
(7)
= 0.1473; 𝑃 > 0.8), ruling out the possibility
that the observed induction of RAG1mRNA (see Figure 1(b))
could be due to residual blood, and thus blood cells, in the
examined brain tissues.
3.2. Sequence Analysis of PCR Products Amplified from the
Hippocampus, Amygdala, and Thymus. We next set out to
confirm the sequence identity of the PCR products from
amygdalar and hippocampal tissues amplified using the set of
primers designed to target RAG1 mRNA in our experiments
presented above. In addition to amygdalar and hippocampal
RNA samples, we also utilized thymus RNA, since this tissue
is known to physiologically expressRAG1 due to its role in the
immune system [45–48]. Supplementary Figures 1A and B
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Figure 1: Context fear conditioning induced upregulation of RAG1 mRNA in the amygdala. RAG1 mRNA levels were measured in the
hippocampus and the amygdala on a time course at 15min, 30min, and 1 h after conditioning. (a) Normalized mRNA data showed no
significant differences when examining hippocampal RAG1 mRNA Na¨ıve (N) or the conditioned (C) groups sacrificed at 15, 30, or 60 min
after training. (b) In contrast, context fear conditioning results in a significant, rapid, and transient induction in RAG1 mRNA levels in the
amygdala (Naı¨ve versus C15min, ∗𝑃 < 0.05; Na¨ıve versus C30min, #𝑃 < 0.05; Na¨ıve versus C60min, 𝑃 > 0.05; C60min versus C30min,
+
𝑃 < 0.05; and C60min versus C15min, 𝑃 > 0.05). (c) We sacrificed animals from the conditioned (C), CO, or SO groups 15min after their
respective associative or nonassociative training. Normalized expression confirmed the significant induction at 15min of amygdalar RAG1
mRNA after context fear conditioning compared to Na¨ıve, CO, and SO groups and showed no statistical difference between Naı¨ve, CO, or
SO controls (SO15min versus C15min, #𝑃 < 0.05; SO15min versus Naive, 𝑃 > 0.05; SO15min versus CO15min, 𝑃 > 0.05; CO15min versus
C15min, ++𝑃 < 0.01; CO15min versus Naive, 𝑃 > 0.05; and Na¨ıve versus C15min ∗∗𝑃 < 0.01).
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(in Supplementary Material available online at http://dx.doi
.org/10.1155/2016/1752176) depict the representative results of
amplification curves, as well as our melting curve analysis,
respectively, for RAG1 and gapdh mRNAs. Results of ampli-
fication and melting temperature curves of RAG1 and gapdh
are depicted to show the cycle thresholds (Ct) for both genes
and the specificity of the amplification products, respec-
tively. Importantly, the results of the melting curve analyses
consistently demonstrated that only one specific product
per primer-gene set was generated. The RAG1 amplification
products amplified by standard PCR were also visualized
by agarose gel electrophoresis (Supplementary Figure 1C).
Cloning and sequencing of these PCR products amplified
from amygdala, hippocampus, and thymus confirmed their
identity as RAG1 (Supplementary Figures 2D–F) or gapdh
(data not shown). Sequencing electropherograms from RAG1
PCR products are shown in Supplementary Figure 2D.
PCR fragment sequences from amygdala, hippocampus,
and thymus were aligned using ClustalW2 (Supplementary
Figure 2E) and compared with Mus musculus RAG1 ref-
erence sequence NM 009019.2 (Supplementary Figure 2F).
BLAST analysis confirmed the molecular identity of RAG1
PCR products from amygdala, hippocampus, and thymus
showing 100% matched identity to Mus musculus RAG1
(Ref|NM 009019.2) in mouse genome BLAST analyses with
an 𝐸-value of 2e − 19.
3.3. RAG1 Protein is Localized within Amygdalar Neuronal
Cells. RAG1 is the key endonuclease of V(D)J recombination
in immune cells introducing, together with RAG2, DSBs in
antigen receptor genes at their RSSs [34, 36, 37, 42]. Previous
reports have also suggested that the transcript encoding
RAG1 is expressed in nervous cells [34–37, 49]. We there-
fore considered it important to determine whether RAG1
protein expression is localized to amygdalar neurons. Dou-
ble immunofluorescence of RAG1 antibody with neuronal
nuclear marker, NeuN, was performed on brain coronal
sections from animals perfused 1 h after context fear con-
ditioning. Representative images obtained from confocal
microscopy examination of the amygdalar areas of brain
sections double-labeled with RAG1 (Alexa Fluor 488; green
signal) and NeuN (Alexa Fluor 568; red signal) are shown in
Figure 2(a). These findings indicate that RAG1 appeared to
be expressed predominantly in neurons, as suggested by the
colocalization between RAG1 and NeuN. It is also important
to mention that while all RAG1 positive cells were neurons,
not all neurons showed RAG1 reactivity, suggesting that only
a subset of cells expressed RAG1.Themolecular specificity of
the RAG1 antibody was confirmed by Western blot analyses
(Figure 2(b)). Tissue punches from amygdala were obtained
1 h after context fear conditioning. Additionally, reference
tissues from thymus and bonemarrow, known to express high
levels of RAG1 [45–48], and muscle (negative control) were
dissected. All tissues were subjected to protein extractions
for Western blot analyses. RAG1 protein expression from the
amygdala was compared by comigration with bone marrow
and standard molecular weight (MW) ladder (Figure 2(b),
Panel 1), and thymus (Figure 2(b), Panel 2) extracts, respec-
tively. Both sets of experiments confirmed comigration of
a band of approximately 120KD corresponding to RAG1 pro-
tein. In contrast, amygdalar protein extracts compared with
muscle extracts (Figure 2(b), Panel 3) showed no comigration
of bands indicating, as expected, that RAG1 is specifically
expressed in the amygdala (Figure 2(b), Panel 1), as well as
bone marrow (Figure 2(b), Panel 1) and thymus (Figure 2(b),
Panel 2), but not in muscle tissue (Figure 2(b), Panel 3). Fur-
thermore, RAG1 antibody preabsorption assays with either
bonemarrow ormuscle protein extracts, which display either
detectable or undetectable RAG1 expression, respectively (see
Figure 2(b), Panel 1 versus Figure 2(b), Panel 3, resp.), showed
that only bone marrow protein extracts (known to express
RAG1; see Figure 2(b), Panel 1) were able to block the∼120KD
band from amygdalar protein extracts in the Western blots
(Figure 2(b), Panel 4). These results indicate that RAG1 anti-
body was preabsorbed (blocked) only by RAG1 protein
expressing tissue (bone marrow).
3.4. RAG1 Plays a Functional Role in LTM Consolidation
of Context Fear Conditioning. Our gene expression studies
demonstrated that RAG1 mRNA is specifically induced in
the amygdala between 15min and 30min as a result of
context fear conditioning and it returns to basal levels 1 h
after training (see Figure 1(b)). This suggested that RAG1
might play a role in LTM processes. To examine the possible
functional role of RAG1 in LTM consolidation of context fear
conditioning, we used an antisense approach to knock down
RAG1 expression in the amygdala (the brain region where
induction was observed) and examined the effects of such
knockdown on LTM of context fear conditioning. Animals
were implanted with bilateral cannulae directed to the amyg-
dala. Cannulae placement confirmation using thionine was
highly precise and consistent, showing that injectors specif-
ically targeted regions just above the amygdalar complex.
Importantly, only the behavioral data of animals for which
thionine staining confirmed correct cannulae localization
were used to determine the effects of the oligonucleotides
treatment. Representative schematics illustrating the distri-
bution of cannulae placements throughout the amygdala for
animals used in our antisense behavioral experiments are
depicted in Figure 3(a). Additionally, we examined the dif-
fusion and incorporation of RAG1 antisense oligonucleotides
in the amygdala (Figures 3(b) and 3(c)) through consecutive
rostrocaudal sections. Diffusion of the microinfused FITC-
RAG1 antisense oligonucleotide was concentrated within the
anterior, posterior, and ventral basolateral amygdala (BLA). It
was also observed that FITC-RAG1 antisense oligonucleotide
was clearly incorporated into the cells within these amygdalar
regions (Figure 3(d)).
We next evaluated the effects of amygdala RAG1 anti-
sense treatment on LTM of context fear conditioning. Male
C57BL/6 mice were microinfused bilaterally into the amyg-
dala with RAG1 antisense or random oligonucleotides (𝑛 =
16, each) 1 h before conditioning training. The top panel of
Figure 4 depicts the experimental design of Figures 4(a)–4(c)
and 4(d), respectively. We used the 1 h pretraining infusion
time point in order to allow for the antisense oligonucleotides
to be diffused into the brain parenchyma and be taken up
by neuronal cells prior to subjecting the animals to context
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Figure 2: RAG1 protein expression in amygdalar neuronal cells. Amygdalar coronal sections of context fear conditioning-trained
mice, perfused 1 h after conditioning, were used for immunofluorescence and analyzed by confocal microscopy. Antibodies from
immunofluorescence were validated by Western blot analysis. (a) Amygdalar area representative images of a double immunostaining using
RAG1 antibody labeled with Alexa Fluor 488, green channel signal, and NeuN antibody labeled with Alexa Fluor 568, red channel signal.
The left panel shows the NeuN positive neuronal nuclei, while the middle panel depicts RAG1 immunopositive cells. The right panel is the
merge image showing colocalization of the NeuN neuronal nuclei marker and RAG1. Arrows point to some of the RAG1 immunopositive
neurons. These immunofluorescent images revealed colocalization of RAG1 protein expressing cells with those expressing NeuN, suggesting
the presence of RAG1 in neurons, although not all neurons expressed RAG1. (b) Tissue punches from amygdala (Amy) were obtained 1 h after
context fear conditioning and analyzed in Western blot by comparative comigration with a standard molecular weight (MW) marker and
protein extracts frombonemarrow (BM) ((b)-1) and thymus (Thy) ((b)-2). Both sets of experiments consistently showed comigration between
the tissues with a band corresponding to ∼120KD of RAG1 protein (green channel corresponding to RAG1 and red channel corresponding
to beta-actin, ∼42KD); prestained molecular weight (MW)marker (ladder) was included in all theWestern blots. ((b)-3) Additionally, tissue
protein extracts from leg muscle (Mus) (negative control) were analyzed compared to amygdalar extracts with respect to RAG1 expression.
As expected, RAG1 was not expressed in muscle compared to amygdala ((b)-3), bone marrow ((b)-1), and thymus ((b)-2). ((b)-4) RAG1
antibody preabsorption assays, either with muscle or with bone marrow extracts, showed that only bone marrow extracts, which express
RAG1 as opposed to muscle, were able to block the ∼120KD band from amygdalar protein extracts in theWestern blots, indicating that RAG1
antibody was preabsorbed (blocked) only by RAG1 protein expressing tissue (bone marrow).
fear conditioning. For context fear conditioning, mice were
placed inside a conditioning context (the chamber, CS) before
receiving three consecutive foot shocks (US). As seen in Fig-
ure 4(a), mice receiving either antisense or random acquired
the task normally, displaying no significant differences in
acquisition of fear conditioning, measured as the progressive
enhancement of freezing behavior during a 60 s after-shock
period. As stated, Two-Way RM ANOVA followed by Bon-
ferroni posttesting found no effect by treatment, although
animals in both groups acquired the task, demonstrating
that the infusions did not impair the animals’ response in
developing and expressing fear during the conditioning
experience (Treatment Factor: 𝐹(1, 0.8457) = 0.007142, 𝑃 >
0.9; Training Factor 𝐹(3, 7863) = 109.8, ∗∗∗𝑃 < 0.0001;
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Figure 3: Distribution of cannula placements and RAG1 antisense oligonucleotide diffusion within the amygdala. After behavioral treatments
with RAG1 antisense or random oligonucleotides, animals were microinfused the next day with thionine to verify cannulae injectors’
placement. Another set of animals was used to observe FITC-labeled RAG1 antisense diffusion. (a) Schematic representation of the amygdala
at different rostrocaudal planes illustrating the position of cannulae injectors determined by thionine microinfusion. Injector tips for each
cannula are represented by dark spots. (b) FITC-RAG1 antisense diffusion within the amygdalar complex; arrow indicates the injector’s tip.
(c) Schemes of coronal sections showing the diffusion of FITC-RAG1 antisense diffusion into the amygdala of animals decapitated 3 h after
fluorescent oligonucleotide infusion. FITC-RAG1 antisense diffusion is represented by green shading from anterior to posterior areas of the
amygdalar complex.The numbers in (a) and (c) indicate the distance from bregma inmillimeters. A total of 4 mice were used in these studies.
(d) Photomicrograph at higher magnification of FITC-RAG1 antisense diffusion showed clearly incorporation into the cells (depicted by the
arrows) within amygdalar regions.
Interaction: 𝐹(3, 7.457) = 0.1041, 𝑃 > 0.9; and Subject
Matching: 𝐹(25, 118.4) = 1.653, ∗𝑃 < 0.05). Posttesting
analysis did not identify any specific significant differences
between the groups during the habituation or the 1st, 2nd,
or 3rd trials of training (𝑃 > 0.05, each comparison). These
results indicate that both groups were similarly capable of
learning the task. LTMwas then tested 24 h after conditioning
by placing animals back into the conditioning chamber. Dur-
ing the LTM test, mice remained in the chamber for 4min in
order to measure their freezing response to the context (CS).
The bar graph in Figure 4(b) shows that during LTM testing
mice treated with RAG1 antisense gapmer oligonucleotides
displayed significantly less percent freezing to the condition-
ing context than random oligonucleotide controls (Student’s
𝑡-test; 𝑡
(25)
= 2.602; ∗𝑃 < 0.05). Thus, pretraining antisense
microinfusion into the amygdala significantly impaired LTM
as tested 24 h after conditioning.
To confirm themolecular effectiveness of our knockdown
by gapmer antisense oligonucleotides of RAG1 in the amyg-
dala, we performed quantitative real-time PCR experiments.
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Figure 4: RAG1 antisense amygdalar treatment impaired consolidation of context fear conditioning. Top panel: diagram depicting the
experimental design of these experiments for pretraining or posttraining amygdalar antisense or random oligonucleotide microinfusion
experiments. In the pretrainingmicroinfusion experiments,mice receivedRAG1 antisense or randombilateral oligonucleotidemicroinfusions
directed at the amygdala 1 h before conditioning followed by either LTM testing or molecular evaluation. LTM was tested 24 h after
conditioning. For molecular evaluation of antisense treatment effectiveness, another group of mice was sacrificed 30min after conditioning
and amygdalar RNA was used for real-time PCR. In the posttraining microinfusion experiments, mice were conditioned, returned to their
home cages, and received microinfusions of antisense or random oligonucleotides 5 h after training and returned to their home cages until
next day. Nineteen (19) hours later (24 h after conditioning), mice were reexposed to the conditioning chamber without any shocks in order to
test LTM. (a) Mice receiving either RAG1 antisense or random oligonucleotide treatment displayed no significant differences during memory
acquisition measured as the progressive enhancement of freezing behavior (Two-Way ANOVA, Treatment Factor: 𝐹(1, 0.8457) = 0.01015,
𝑃 > 0.9; Training Factor 𝐹(3, 7863) = 94.37, ∗∗∗𝑃 < 0.0001; Interaction: 𝐹(3, 7.457) = 0.08950, 𝑃 > 0.9). Bonferroni posttesting analysis
did not identify significant differences between the groups during the habituation or the 1st, 2nd, or 3rd trials of training (𝑃 > 0.05,
each comparison), indicating that both groups were similarly capable of learning the task. (b) LTM was tested 24 h after conditioning.
The bar graph shows that, unlike the results obtained for acquisition, mice treated with RAG1 antisense gapmer oligonucleotides displayed
significantly less percent freezing to the conditioning context than random oligonucleotide controls during the LTM test (Student’s 𝑡-test;
𝑡
(25)
= 2.602; ∗𝑃 < 0.05). (c)Themolecular effectiveness of our knockdown by gapmer antisense oligonucleotide of RAG1 in the amygdala was
determined by quantitative real-time PCR. Mice were infused 1 h before context fear conditioning with bilateral RAG1 antisense or random
oligonucleotides and decapitated 30min after conditioning. RAG1 mRNA normalized against gapdh mRNA showed that treatment with
RAG1 antisense gapmer oligonucleotides effectively knocked down the levels of RAG1 amygdalar mRNA compared to the random controls
(Student’s 𝑡-test; 𝑡
(16)
= 3.947; ∗∗𝑃 < 0.005). No significant differences in the levels of gapdh were observed between treatments (data not
shown). (d)We used 5 h posttraining amygdalar microinfusions of RAG1 antisense oligonucleotides or random controls with a different set of
animals without any pretraining infusion and LTM was tested 24 h after training. Unlike in the pretraining microinfusion experiments, both
the antisense and random posttraining-infused mice displayed similar levels of conditioned freezing during the LTM test (Student’s 𝑡-test;
𝑡
(12)
= 2.835; 𝑃 > 0.7).
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The antisense approach is a well-established technique and
has been extensively used in the brain to assess memory
function [50–54]. Our RAG1 antisense gapmer targets the
translation initiation codon, thus causing a knockdown of
RAG1 protein by translational repression [55–58]. Addition-
ally, the gapmer oligonucleotide contains a central block
of deoxynucleotides sufficient to induce the endogenous
mechanism of RNA:DNA duplex degradation by ribonucle-
ase H (RNase H) cleavage and thus targeted degradation
of mRNA hybridized with the antisense oligonucleotide.
Moreover, the antisense gapmer is flanked by blocks of 2󸀠-
O-methyl modified ribonucleotides that protect the internal
block from exonuclease degradation [58–61], which increases
the stability andhalf-life of the unhybridized gapmer oligonu-
cleotide itself. Testing the effectiveness of antisense treatment
in the brain has been used by us and others by measuring
knockdown of target gene mRNA levels using real-time
PCR [62–64]. To test the molecular effectiveness of the
RAG1 gapmer antisense oligonucleotide, mice were infused
1 h before context fear conditioning with bilateral RAG1
antisense (𝑛 = 8) or random (𝑛 = 10) oligonucleotides.
Amygdalar RAG1mRNA expression was analyzed in trained
mice sacrificed 30min after conditioning, the time point
of highest expression seen in the time course studies (see
Figure 1(b)). RAG1 mRNA was normalized against gapdh
mRNA as above. As seen in Figure 4(c), treatment with
RAG1 antisense gapmer oligonucleotides effectively knocked
down the levels of RAG1 amygdalar mRNA compared to the
random controls (Student’s 𝑡-test; 𝑡
(16)
= 3.947; ∗∗𝑃 < 0.005).
No significant differences in the levels of gapdhwere observed
between treatments (data not shown). These results show
the effectiveness and selectivity of the antisense treatment on
knocking down RAG1 expression.
The results presented so far suggest that RAG1 is required
in the early phase of LTM consolidation. Molecular events
leading to LTM consolidation occur within the early time
window during the first 6 h after training, although consol-
idation processes may last from hours to days and even the
transfer of memories to other cortical regions might take
longer time periods [65–67]. For instance, it is reported that,
in rodents, fear memories require distinct molecular and
temporal transcriptional/translational events lasting up to 6 h
[65, 66, 68, 69] after learning experiences. More related to
this work, our previously reported findings suggested that
DNA ligase-dependent NHEJ events, which are associated in
general with the repair of DNA DSBs, but also with V(D)J
recombination processes in the immune system [26, 70, 71],
are also induced rapidly in the hippocampus after context
fear conditioning [32]. In addition, we also reported that the
function of the flap structure-specific DNA endonuclease 1
(Fen1), known to be involved in DNA recombination/repair
processes [29, 72], is induced in the amygdala 3 h after condi-
tioned taste aversion (CTA) learning and is required for LTM
consolidation [29]. Hence, for our next set of experiments,
we used delayed posttraining amygdalar infusions of RAG1
antisense oligonucleotides or random controls in order to
better assesswhetherRAG1 is specifically involved in the early
stages of consolidation. Animals assigned to the antisense
or the random treatments were implanted with cannulae as
the animals in the pretraining infusion experiment (Figures
4(a) and 4(b)). Mice of both groups were subjected to context
fear conditioning as above, except that these animals had
not received pretraining infusions of gapmer antisense or
random oligonucleotides before exposing them to the task.
Immediately after training, mice were returned to their home
cages and then subjected to bilateral intra-amygdalar infu-
sions of either RAG1 antisense or random oligonucleotides
5 h after training. LTM was tested 24 h after conditioning.
The results depicted in Figure 4(d) show that, unlike in
the pretraining microinfusion experiments (see Figure 4(b)),
both the antisense and random posttraining-infused mice
(𝑛 = 7, each group) displayed similar levels of conditioned
freezing during the LTM test (Student’s 𝑡-test; 𝑡
(12)
= 2.835;
𝑃 > 0.7). Overall, these behavioral results suggest that, for
LTM of context fear conditioning to be established, RAG1 is
required at early, rather than later, time points following the
time of learning experiences.
Finally, in additional control experiments we tested the
effects of RAG1 gapmer antisense treatment on memory
reconsolidation of context fear conditioning. We used this
additional control because our previous studies using the
DNA ligase inhibitor ara-C, which blocks DNA repair by
blocking NHEJ activity [31, 73, 74], showed that treatment
with this inhibitor blocked LTMconsolidation, but not recon-
solidation, of context fear conditioning [32]. Such results also
suggested that DNA recombination/repair mechanisms are
specific to the initial stages of LTM consolidation and are not
involved inmemory reconsolidation processes activated after
the retrieval of memories that have already been established.
For these experiments (see the top panel of Figure 5 for depic-
tion of the experimental design), a set of animals was bilat-
erally implanted with cannulas to target the amygdala (see
Section 2). This protocol was performed similar to [32, 38].
On day 1, mice weremicroinfused with saline (as a stress con-
trol) and were trained 1 h later in context fear conditioning.
All animals were returned to their home cages immediately
after training. On day 2 (24 h after training), animals were
microinfused with either random (𝑛 = 5) or antisense (𝑛 = 6)
gapmer oligonucleotides. Microinfusions were given 1 h prior
to a 90 s reexposure period to the conditioning chamber in
order to induce memory retrieval. Next, all animals were
returned to their home cages. Finally, on day 3 (48 h after
training), all mice were again exposed to the conditioning
chamber (CS) for 2min to measure freezing responses. As
seen in Figure 5(a), no significant differences were observed
during acquisition between the animals assigned to anti-
sense or random RAG1 gapmer oligonucleotide treatment.
Accordingly, Two-Way RM ANOVA followed by Bonfer-
roni posttesting found no effect by treatment assignment,
although animals in both groups acquired the task normally,
demonstrating that the infusions did not impair the animals’
response in developing and expressing fear during the condi-
tioning experience (Treatment Factor: 𝐹(1, 8.194) = 3.979,
𝑃 > 0.05; Training Factor 𝐹(3, 3134) = 1725, ∗∗∗𝑃 <
0.0001; and Interaction: 𝐹(3, 1.069) = 0.5881, 𝑃 > 0.6).
Posttesting analysis did not identify any specific significant
differences between the groups during the habituation or the
1st, 2nd, or 3rd trials of training (𝑃 > 0.05, each comparison).
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Figure 5: RAG1 antisense amygdalar treatment does not interfere with reconsolidation of context fear conditioning. To test the effects of
RAG1 gapmer antisense treatment on memory reconsolidation of context fear conditioning, another set of animals was bilaterally implanted
with cannulas to target the amygdala. Top panel: diagram depicting the experimental design. On day 1, mice were trained in context fear
conditioning and immediately returned to their home cages. Antisense or random oligonucleotides were microinfused into the amygdala 1 h
beforememory reactivation onday 2.The effect of antisense or randomoligonucleotide treatment onLTMreconsolidationwas assessed onday
3, 48 h after conditioning. (a) On day 1, mice were microinfused with saline 1 h before training and returned to their home cages immediately
after conditioning. Two-Way RM ANOVA and Bonferroni posttesting demonstrated that the infusions did not impair the animals’ response
in developing and expressing fear during the conditioning experience (Treatment Assignment Factor: 𝐹(1, 8.194) = 3.979, 𝑃 > 0.05; Training
Factor𝐹(3, 3134) = 1725, ∗∗∗𝑃 < 0.0001; and Interaction:𝐹(3, 1.069) = 0.5881,𝑃 > 0.6). (b) On day 2, animals weremicroinfused with either
random or antisense gapmer oligonucleotides 1 h prior to a 90 s reexposure period to the conditioning chamber in order to induce memory
retrieval and returned to their home cages. For the reconsolidation test, on day 3 (48 h after training), mice were reexposed to the conditioning
chamber (CS) for 2min to measure freezing responses. No significant differences between the freezing responses of antisense or random
gapmer oligonucleotide treated animals on day 2 (b) or on day 3 (b) were observed (Two-Way ANOVA: Treatment Factor: 𝐹(1, 3.068) =
0.009017, 𝑃 > 0.9; Training Factor 𝐹(1, 146.5) = 0.4307, 𝑃 > 0.5; Interaction: 𝐹(1, 0.001515) = 0.00004453, 𝑃 > 0.9). Bonferroni posttesting
identified no difference between treatments in the reexposure and reconsolidation tests, respectively (𝑃 > 0.05, each comparison).
These results indicate that both groups were similarly capable
of learning the task. More importantly, as seen in Figure
5(b), with respect to our question ofwhether amygdalarRAG1
antisense treatment impaired memory reconsolidation or
not, the results identified no significant differences between
the freezing responses of antisense or random gapmer oligo-
nucleotide treated animals on day 2 (memory retrieval/
reexposure test) or on day 3 (reconsolidation test) (Two-Way
ANOVA: Treatment Factor: 𝐹(1, 3.068) = 0.009017, 𝑃 > 0.9;
Training Factor 𝐹(1, 146.5) = 0.4307, 𝑃 > 0.5; Interaction:
𝐹(1, 0.001515) = 0.00004453, 𝑃 > 0.9). Bonferroni post-
testing identified no difference between treatments in the
reexposure and reconsolidation tests, respectively (𝑃 >
0.05, each comparison). Overall, these results are congruent
with our previous findings suggesting that DNA DSB repair
mechanisms are possibly relevant only for the initial stages
of LTM consolidation and are not utilized when established
memories are retrieved or reactivated [32].
4. Discussion
We previously reported that a DNA repair system involving
DNA ligase function and NHEJ activity is induced and
required for memory consolidation [32]. Additionally, stud-
ies with TdT, a specialized polymerase involved in V(D)J
recombination [71, 75, 76], showed that TdT expression is
induced as a result of new experience in brain regions
involved in memory formation and is required for normal
learning and memory in mice [30]. Our subsequent studies
identified the endonuclease Fen1, known to be involved in
DNA recombination/repair processes, as being induced after
associative learning and being required for LTM formation
[29]. Moreover, in more recent studies, mice exposed to a
novel environment [27] were shown to accumulate DNA
DSBs in the brain, including the hippocampus. These DNA
lesions were shown to be transient, as they were repaired
after 24 h, highlighting the importance of the DNA repair of
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such DSBs, which if left unrepaired could ensue in neuronal
dysfunction, and also suggesting that they could be related
to learning processes associated with exposure to novel
environments. In addition, more recent studies showed that
DNADSBs are introduced in the promoters of early-response
genes and are required for their induction in response to neu-
ronal activity, synaptic plasticity processes, and context fear
conditioning [28]. Accordingly, these studies are reminiscent
of our previous findings showing thatNHEJ activity repairing
DNA DSBs is rapidly induced in the hippocampus, but not
the insular cortex, following context fear conditioning inmice
[32].
Our present studies further support the notion that
DNA recombination/repair machineries particularly involv-
ing DNA endonucleases might be involved in learning and
memory processes. Specifically, we identified and character-
ized the expression of RAG1 in wild type C57BL/6 mice brain
during context fear conditioning and confirmed that RAG1
expression is required in the amygdala for early consolidation
of fear memory. These findings further confirm previous
reports suggesting the role of RAG1 in some behavioral
paradigms and support the notion that DNA recombina-
tion/repair mechanisms may be required in LTM.
4.1. RAG1 Induction in the Amygdala Is Associated with
Context Fear Conditioning Learning. Using quantitative real-
time PCR, we compared hippocampal and amygdalar RAG1
expression of context fear conditioning-trained animals dur-
ing a time course of 15min, 30min, and 1 h after condition-
ing. The levels of hippocampal RAG1 mRNA after training
remained similar to Na¨ıve basal levels. On the other hand, we
did observe a rapid and transitory induction of RAG1mRNA
in the amygdala between 15 and 30min, which returned
to baseline at 1 h, suggesting that RAG1 is tightly regulated
at the level of transcription in the amygdala compared to
the hippocampus. This is consistent with previous reports
supporting the major role of the amygdala in fear memory,
compared to the hippocampus [77–79]. Additionally, we
compared amygdalar expression of RAG1 in conditioned
animals and mice subjected to the individual components
of this aversive learning paradigm: context-only and shock-
only. Interestingly, we found that RAG1 mRNA levels are
significantly higher only in context fear conditioning-trained
animals compared with those trained with the individual,
unpaired, components of the associative paradigm, as well as
with naive. The specific induction of RAG1 in conditioning
paired stimuli suggested that such induction was not merely
a correlate of fear itself, but it could be involved in associative
learning and LTM formation. In contrast, previous reports
have found that immediate early genes involved in general
neuronal activation such as c-fos are induced in context fear
conditioning, but also in context-only (hippocampus) and
shock-only (amygdala) animal groups [80–83]. However, the
specific induction of RAG1 to conditioned animals in the
amygdala suggests that it does not correspond to the response
of a general pattern of neuronal activation.
Because of the widely established role of RAG1 during
DNA rearrangement, a process thought to be highly specific
to nuclei of immune cells, wewanted to determine the cellular
localization of this endonuclease within the amygdalar tissue
after context fear conditioning.Thus, after ruling out the pos-
sibility that the observed changes in RAG1 mRNA after con-
ditioning could be due to the presence of residual blood cells
in the tissues examined, we performed immunofluorescence
analysis of the RAG1 protein. Importantly, for immunoflu-
orescence, brains from trained animals sacrificed 1 h after
conditioning were also perfused with PBS1X to remove
residual blood and subsequently with paraformaldehyde for
tissue fixation. Results demonstrated that NeuN, amarker for
neuronal nuclei, was colocalized with RAG1 expression, sug-
gesting that RAG1-positive cells in the amygdala after training
are predominantly neurons. Interestingly, not all neurons
marked with NeuN were colabeled with RAG1, suggesting
that DNA recombination/repair machineries associated with
this factor might be restricted to only a subset of cells in the
amygdala after context fear conditioning.
4.2. RAG1 Is Required for Consolidation, but Not Reconsoli-
dation, of Context Fear Conditioning. The amygdala plays a
critical role for LTM consolidation and for the representation
of theUS component of context fear conditioning [78, 79, 84–
86]. We found that RAG1 mRNA is specifically induced in
the amygdala, but not in the hippocampus, after training.
Interestingly, some reports have demonstrated that the effect
of amygdalar lesions on fear memory impairment is stronger
than the effect of hippocampal lesions, suggesting a major
role of the amygdala in fear memory [78, 79]. Hence,
we decided to extend our studies by using experiments
addressing the functional role of amygdalar RAG1 on LTM
of context fear conditioning. We found that RAG1 antisense,
but not random, oligonucleotides were effective in selectively
suppressing the levels of amygdalar RAG1 mRNA and also
impaired LTM of context fear conditioning without affecting
acquisition of the task. Animals microinfused with antisense
or random oligonucleotides 5 h after conditioning showed
no effects in LTM by the antisense targeting, suggesting that
RAG1 is only required in the early phase of LTM formation.
Furthermore, RAG1 antisense or random oligonucleotides
infused into the amygdala 1 h prior to memory reactiva-
tion of previously trained untreated mice resulted in no
effect in either memory retrieval or memory reconsolida-
tion. Consistent with these findings, we previously found
that administering ara-C, an inhibitor of DNA ligase and
of NHEJ activity shown to block LTM consolidation of con-
text fear conditioning, just prior to memory reactivation had
no effect in memory reactivation or memory reconsolidation
[32]. Altogether, these results suggest that, unlike CREB
inactivation and general protein synthesis inhibition [38, 87,
88], blockade of DNA recombination/repair processes during
memory reactivation does not interfere with reconsolidation
of fear conditioning [32].The fact thatmechanisms associated
with the introduction of DNA DSBs are restricted to the
early phases of LTM consolidation and are not activated as a
result ofmemory retrieval might represent amechanism for a
balance that would allow neurons to maintain their integrity
by not overriding their mechanisms for DNA repair, which
could occur if these lesions were to be introduced every time
an established memory is retrieved.
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The results presented above are consistent with previous
studies using RAG1-knockout (RAG1−/−) and RAG1-deficient
mice (RAG1−/+).RAG1−/−mice showed reduced levels of fear-
fulness for somemeasures of fear-motivated behavior in both
the open-field behavior test and the elevated-plus maze [36].
Additionally, RAG1−/+ exhibited impaired social recognition
memory [37]. Moreover, RAG1−/− mice showed memory
impairment compared with wild type in the Morris water
maze [89]. These findings with RAG1−/− and RAG1−/+ mice
are interesting; however, it is known that, in some cases, such
gene targeting models might be masked by compensatory
mechanisms, or developmental and physiological side effects,
sometimes undetectable, because the mutation targets all
cells [50, 90–92]. For instance, mice presenting inactivating
mutations or deletion of the RAG1 gene show severe com-
bined immunodeficiency (SCID) caused by small lymphoid
organs, impaired development of B and T lymphocytes,
and inability to perform V(D)J recombination, but with no
obvious neuroanatomical abnormalities [93–97]. In contrast,
RAG1−/+ mice in which one copy of the RAG1 gene is deleted
and thus which are heterozygous for the RAG1 gene (−/+),
are immunocompetent and indistinguishable from wild type
mice, displaying normal lymphocytes differentiation and
V(D)J recombination [93, 95]. Nevertheless, neither of the
knockout or heterozygous models mentioned above have
regional or temporal control for RAG1 gene inactivation.
The antisense oligonucleotide approach has the advantage
of brain region specificity in the region of interest (the
amygdala) at a specific time point. For instance, knockout
mice targeting the transcription factor encoded by the imme-
diate early gene c-fos show normal acquisition and LTM
[50]. However, acute knockdown with antisense oligonu-
cleotide to specific brain regions involved in the learning
paradigm inhibits LTMofwild typemice [50], suggesting that
compensatory mechanisms are activated in the absence of
Fos-mediated transcription in knockout models. Conversely,
CREB mutants and knockouts display memory disruption
in fear conditioning and in a wide range of behavioral
paradigms [11, 98, 99]. Similarly, targeted injection of CREB
antisense into the hippocampus or into the amygdala results
in disruption of LTM in a variety of tasks [53, 100]. Similar to
our studies reported here with gapmer antisense oligonucleo-
tides, a study using shRNAs targeting RAG1 delivered with
lentiviral vectors into the CA3 region of the rat hippocampus
was used to assess the effects of suppressing RAG1 expression
on spatial learning in the Morris Water maze [101]. These
studies demonstrated that suppressing RAG1 expression in
the hippocampal CA3 region does impair spatial learning in
rats. The authors also examined the effects of such suppres-
sion on context fear conditioning. Similar to our findings
here with respect to RAG1 amygdalar knockdown in mice,
their findings suggest that hippocampal expression of RAG1
is necessary for LTM of context fear conditioning, although
no experiments were done to examine whether changes in
RAG1 expression occurred either in the hippocampus or in
the amygdala as a result of learning in either of the paradigms.
With respect to the findings on context fear conditioning, it is
important to state that in our studies reported here we did not
observe hippocampal induction of RAG1 mRNA levels after
conditioning (see Figure 1(a)); that is, RAG1 mRNA levels
remained at their basal Na¨ıve levels at each of the time
points examined. We cannot rule out, however, and in light
of the study mentioned above, that the basal constitutive
expression of RAG1 in the hippocampus after context fear
conditioning may play a role in LTM, as well as the induced
amygdalar expression. Finally, as suggested previously [102]
it is possible that different molecular mechanisms operate in
consolidation of distinct learning paradigms, either spatial
learning or context fear conditioning, which might involve
regulated or constitutive RAG1 expression and function in
distinct regions of the brain.
Our findings on RAG1 induction and functional knock-
down studies with antisense, together with previous reports
on RAG1−/+ [36, 89] and RAG1−/+ [58] mouse models, sup-
port the possibility that this DNA endonuclease, which intro-
duces DNA DSBs, is required for associative memory forma-
tion. Additional support for the required role ofRAG1 in LTM
is provided by the observation that RAG1 induction is specif-
ically related to the pairing of individual conditioning stimuli
(Figure 1(c)) and the fact that the amnesic effect of amygdalar
knockdown of RAG1 is evident 24 h after acquisition of con-
text fear conditioning (Figure 4(b)). The crucial question at
this time is whether RAG1 indeed is involved in introducing
DNA DSBs in response to learning and whether the repair
of such DNA lesions is required for LTM. Although the
data presented here and that reported previously concerning
the experience-dependent expression of factors specifically
related to V(D)J recombination in brain regions involved
in memory formation further strengthen this view [27–32],
additional published data could suggest that such changes
may not be associated with the introduction of DNA DSBs
and DNA repair. For example, a cytoplasmic form of the P13
kinase member ataxia-telangiectasia mutated (ATM) [103],
known to play a key role in DNA DSB repair, was shown
to play an important role in synaptic plasticity. However, the
studies also suggested that this form of cytoplasmic ATM is
not involved in the key role ofDNADSB repair ascribed to the
nuclear form of the protein. The authors suggested that cyto-
plasmic ATM plays cellular roles in neurons that are inde-
pendent of its role in responding to DNA lesions. Thus, we
cannot rule out at this time that our findings with RAG1 may
be unrelated to its role in introducing DNA DSBs that is well
documented in the immune system. However, in the studies
presented here localization of RAG1 after conditioning was
concentrated in neuronal nuclei in the amygdala, colocalizing
with the neuronal nuclear marker NeuN, suggesting that the
role of RAG1 in the amygdala after learning is associated
with nuclearmachineries such asDNA recombination/repair.
Moreover, our previous reports on experience-dependent
induction of NHEJ activity and DNA repair machineries
suggest that DNA DSBs are generated as a result of learning,
perhaps as a consequence of induced endonuclease activity
such as RAG1, and subsequent DNA repair by induction of
NHEJ/DNA ligase pathway. Overall, based on these findings
we propose that DNA recombination/repair pathways [23],
involving a V(D)J-like mechanism using RAG1, DNA ligase/
NHEJ [31–33], Fen1 [29], and TdT [30], possibly operate
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together with epigenetic and transcriptional/translational
regulation for LTM formation. Such a mechanism could be
responsible not only for regulating the activity of gene pro-
moters and thereby gene expression, but also for increasing
the diversity of the repertoire of genes and proteins required
for synaptic plasticity processes and the establishment of
specific connectivity of neuronal networks and/or the specific
patterns of gene expression involved in the establishment of
specific long-term memories.
5. Conclusion
Thepresent studies have identified and characterized,RAG1, a
gene encoding a key endonuclease that introducesDNADSBs
in recombination processes of the immune system, required
for LTM formation of aversive experiences. In immune cells,
somatic DNA rearrangement is initiated by RAG1, which
exerts endonuclease activity upon the RSSs of V(D)J gene
segments resulting in enhanced diversity of antigen receptor
genes [42, 71, 104, 105]. Because of the well-knownmolecular
function of RAG1 as the DNA endonuclease initiating V(D)J
recombination of T-cell and immunoglobulin receptors in
lymphoid cells, our findings support the proposed role of
DNA recombination/repair mechanisms in LTM processes
[23, 27–32]. Introduction of DNA DSBs, DNA repair, and
DNA rearrangement are not inconsistent with synaptic plas-
ticity models andmechanisms previously described.Thus, an
integrated control of the introduction of DNA DSBs, DNA
repair, DNA rearrangement, epigenetics, and transcriptional
and translational mechanisms may orchestrate gene regula-
tion in memory formation.
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